XYL
49
4
M
37
12
MRK
25
-2
TROW
56
5
MCD
52
2
SE
61
-4
ROK
62
15
BF.B
33
2
PM
62
-2
PSA
58
2
BSX
67
-3
STI
14
-17
AN
58
4
NEE
50
-5
A
43
2
HBI
59
4
KEY
46
3
SEE
56
6
MTB
67
2
NDAQ
62
2
XYL
49
4
M
37
12
MRK
25
-2
TROW
56
5
MCD
52
2
SE
61
-4
ROK
62
15
BF.B
33
2
PM
62
-2
PSA
58
2
BSX
67
-3
STI
14
-17
AN
58
4
NEE
50
-5
A
43
2
HBI
59
4
KEY
46
3
SEE
56
6
MTB
67
2
NDAQ
62
2
Financhill
Back

CytoSorbents 10K Form

Sell
16

CTSO
CytoSorbents

Last Price:
0.95
Seasonality Move:
35.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q CTSO/CytoSorbents Quarterly
2023-08-01 10Q CTSO/CytoSorbents Quarterly
2023-05-02 10Q CTSO/CytoSorbents Quarterly
2022-11-03 10Q CTSO/CytoSorbents Quarterly
2022-08-02 10Q CTSO/CytoSorbents Quarterly
2022-05-03 10Q CTSO/CytoSorbents Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales: $31.08M
Cash Flow: $-2.76M
Price / Cash Flow: 0
Annual Sales: $0.24
Price / Book: 3.87

Profitability

EPS (TTM): -0.36000
Net Income (TTM): $-18.67M
Gross Margin: $17.13M
Return on Equity: -103.21%
Return on Assets: -37.47%

CytoSorbents Earnings Forecast

Key CytoSorbents Financial Ratios

  • The Gross Profit Margin over the past 16 years for CTSO is 55.10%.
  • The Selling, General & Administrative Expenses for CTSO have been equal to 121.84% of Gross Profit Margin.
  • The Research & Development expenses have been 50.60% of Revenue.
  • The Interest Expense is -15.31% of Operating Income.
  • The Net Earning history of CTSO is -91.71% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

CytoSorbents Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CTSO
CUSIP: 23283X
Website: cytosorbents.com

Debt

Debt-to-Equity Ratio: 1.06
Current Ratio: 1.97
Quick Ratio: 1.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CTSO Technical Analysis vs Fundamental Analysis

Sell
16
CytoSorbents (CTSO) is a Sell

Is CytoSorbents a Buy or a Sell?

  • CytoSorbents stock is rated a Sell
    The current CytoSorbents [CTSO] share price is $0.92. The Score for CTSO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.